Last reviewed · How we verify

NCT05984797: INSPIRE

Integrated Short-Term Palliative Rehabilitation in Incurable Cancer

Recruiting now NA Last updated 22 May 2024
What this trial tests

NA trial testing Integrated Short-term Palliative Rehabilitation in Cancer in 340 participants. Currently enrolling.

Timeline
18 April 2024
Primary endpoint
2 October 2025
31 August 2026

Quick facts

Lead sponsorKing's College London
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment340
Start date18 April 2024
Primary completion2 October 2025
Estimated completion31 August 2026
Sites11 locations across Denmark, France, Italy, United Kingdom, Norway

Drugs / interventions tested

Conditions studied

Sponsor

King's College London

Who can join

18 and older, any sex, with Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this intervention trial is to determine if palliative rehabilitation in addition to usual care is more effective than usual care at improving health-related quality of life in patients with incurable solid cancer.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cancer

Currently open trials in the same condition.

Other King's College London trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05984797.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing